glp-1 review receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1-based therapies for diabetes, obesity
Description
The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(/) and LDLr(/) mice by a mechanism that includes inflammatory pathways
30 In 2019, Femminella et al
For something you can actually get today, semaglutide and tirzepatide are the approved options
Drug and Alcohol Dependence, 112424
